Search

The aim was to assess the mid-term results of the E-iliac branched device. Baseline and follow-up data of this monocentric retrospective cohort study including all consecutive patients with aortoiliac aneurysms treated with iliac branched devices between 2016 and 2023 were extracted from the hospital records. Preoperative and follow-up CT scans were analyzed regarding endoleaks, migration, aneurysm sac remodeling, and device patency. Overall, 50 devices were implanted in 38 patients with a median age of 69 (IQR 62–78) years, and 1.6 bridging stent grafts per vessel were implanted through transfemoral (22/50; 44%) or upper extremity access (28/50; 56%). Primary technical success and assisted technical success were 97% (37/38) and 100% (38/38), respectively. No migration, no type I or III endoleaks, no stroke, colonic ischemia, aneurysm rupture, or conversion during the early and mid-term follow-ups (11 months, IQR 5–26) were observed. Aneurysm sac enlargement or shrinkage was observed in 0% (0/38) and 16% (6/38) patients, respectively. E-iliac-related re-interventions were seen only during the early follow-up: two thrombectomies with bare-metal stent relining after thrombosis of the iliac limb. Bridging stent graft and E-iliac patency during the mid-term follow-up were 100%. E-iliac showed encouraging mid-term results in the treatment of aortoiliac aneurysms with high technical success and a low re-intervention rate. [ABSTRACT FROM AUTHOR]

Purpose: Analgesia and sedation protocols are reported to reduce the requirement of sedative and analgesic agents, duration of mechanical ventilation, and length of pediatric intensive care unit (PICU) stay. However, these studies often were conducted based on inhomogeneous cohorts. The aim of this study was the evaluation of a nurse‐driven analgesia and sedation protocol in a homogenous population of infants following corrective surgery for tetralogy of Fallot (TOF). Design and Methods: This retrospective analysis was conducted in a cardiac PICU of a tertiary referral center. Two cohorts of patients who underwent corrective surgery for TOF below the age of 7 months, were retrospectively evaluated before and after implementation of a nurse‐driven analgesia and sedation protocol. We compared peak and cumulative doses of midazolam, morphine, and clonidine, length of PICU stay and time on mechanical ventilation. Results: A total of 33 patients were included in the preimplementation period and 32 during the postimplementation period. Implementation of the nurse‐driven analgesia and sedation protocol had no effect on time on mechanical ventilation (72 hr [24–141] vs. 49 hr [24–98]), but significantly on length of PICU stay (7 days [5–14] vs. 5 days [4–7]). Cumulative doses of midazolam (7.37 mg/kg [4.70–17.65] vs. 5.0 mg/kg [2.70–9.12]) as well as peak doses of midazolam (0.22 mg·kg−1·hr−1 [0.20–0.33] vs. 0.15 mg·kg−1·hr−1 [0.13–0.20]) and morphine (50.0 µg·kg−1·hr−1 [39.7–79.9] vs. 42.5 µg·kg−1·hr−1 [29.7–51.8]) were significantly reduced. The postimplemantation group showed no increase in postoperative complications and adverse events. Practice Implications: The implementation of a nurse‐driven analgesia and sedation protocol is safe in infants following corrective surgery for TOF. It reduces significantly the length of PICU stay, cumulative and peak doses of midazolam and peak doses of morphine. [ABSTRACT FROM AUTHOR]